Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
A Double-Blind, Cross-Over Placebo-Controlled and Active-Controlled Trial To Evaluate The Effect Of A Supratherapeutic Dose Of MK-8189 On The QTc Interval In Participants With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including GlendaleResearchers studied Paliperidone palmitate to find out how it affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including HuzhouResearchers compared SEP-363856 and placebo to find out how the approaches affected psychotic symptoms in adults with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little Rock
A Multicenter, Exploratory, Randomized, Double-Arm, 4-week Study to Evaluate the Overall Effects of Treatment With Abbreviated CT-156 in People With Schizophrenia
This study has finished and is no longer accepting participants.
In New YorkResearchers compared BIIB104 and placebo to find out how the approaches affected memory, attention and other thinking skills in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including BentonvilleA Phase 1b, In-Patient Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of the Co-Administration of Roluperidone and Olanzapine in Adult Subjects With Moderate to Severe Negative Symptoms of Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including Garden GroveThis study evaluated the safety of TV-46000 for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including PhoenixResearchers are studying Iclepertin, tracking side effects to assess long-term safety in people with schizophrenia.
This study ended early.
Multiple locations, including AnaheimResearchers are comparing SEP-363856 and placebo to find out how the approaches affect psychotic symptoms in people with schizophrenia.
This study is no longer accepting new participants.
Multiple locations, including BentonvilleResearchers compared ITI-007 and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockResearchers compared ITI-007, placebo and Risperidone to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little Rock
Evaluation of the Feasibility, Acceptability, and Preliminary Efficacy of a Group Reminiscence Intervention in a Sample of Inpatients With Schizophrenia
This study has finished and is no longer accepting participants.
In ZarqaWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.